FHH-Chr 17BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
17 |
|
20.0 |
IU/g |
2.15 |
8.86 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
45970 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
53.38 |
% |
3.75 |
15.47 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47123 |
461 |
FHH-Chr 17BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
0.54 |
IU/g |
0.08 |
0.22 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47306 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
73.52 |
% |
6.79 |
17.95 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46114 |
461 |
FHH-Chr 17BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
|
10.92 |
ml/min/g |
1.27 |
3.58 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46918 |
461 |
FHH-Chr 17BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
|
6.09 |
ml/min/g |
0.36 |
1.07 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46247 |
461 |
FHH-Chr 17BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
17 |
|
19.74 |
IU/g |
2.1 |
8.67 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
45967 |
461 |
FHH-Chr 17BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
|
8.52 |
ml/min/g |
0.42 |
1.25 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46916 |
461 |
FHH-Chr 17BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
|
10.3 |
ml/min/g |
0.29 |
1.21 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46699 |
461 |
FHH-Chr 17BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
19 |
|
10.42 |
ml/min/g |
0.33 |
1.45 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46701 |
461 |
FHH-Chr 17BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
19 |
|
0.27 |
IU/g |
0.02 |
0.11 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47450 |
461 |
FHH-Chr 17BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
|
5.44 |
ml/min/g |
0.38 |
1.56 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44764 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
72.41 |
% |
4.51 |
13.52 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46112 |
461 |
FHH-Chr 17BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
21.8 |
IU/g |
2.06 |
6.19 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48858 |
461 |
FHH-Chr 17BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
7 |
|
18.48 |
IU/g |
2.99 |
7.9 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48861 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
16 |
post-ischemic value/pre-ischemic value x 100% |
52.79 |
% |
4.3 |
17.2 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47125 |
461 |
FHH-Chr 17BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
8 |
|
0.55 |
IU/g |
0.14 |
0.4 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47310 |
461 |
FHH-Chr 17BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
|
7.86 |
ml/min/g |
1.03 |
2.73 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46249 |
461 |
FHH-Chr 17BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
17 |
|
0.26 |
IU/g |
0.06 |
0.24 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47447 |
461 |
FHH-Chr 17BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
16 |
|
5.36 |
ml/min/g |
0.38 |
1.54 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44766 |
461 |